Pharmafile Logo
Pharmafocus logo
Advanced Search
dentist_teeth

Alzheimer’s drug could point to future of dentistry

January 10, 2017
Manufacturing and Production, Research and Development Alzheimer's drug, Dentistry, dentine, dentist, enamel, teeth

Researchers at King’s College London have discovered a novel use of a drug to treat Alzheimer’s disease, finding that the …

News
takeda_tokyo_hq

Takeda to acquire Ariad in $5.2 billion deal

January 9, 2017
Manufacturing and Production, Sales and Marketing Ariad, Takeda

Takeda has acquired US drug maker, Ariad Pharmaceuticals, in a deal worth $5.2 billion. Takeda has been looking to bolster …

News
abbottweb_2

Abbott completes $25 billion deal for St. Jude

January 9, 2017
Sales and Marketing Abbott, St. Jude

It has been announced that the Federal Trade Commission has approved Abbott Laboratories acquisition of St. Jude Medical for $25 …

News
4420456374_64a3d7e6aa

Pharmafile.com’s top ten most popular articles of 2016

January 9, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

Happy New Year from us here at Pharmafocus! As we leave 2016 behind, take a look at ten of its …

Feature
amgen_hq

Amgen and Immatics enter $1bn immuno-oncology partnership

January 9, 2017
Research and Development, Sales and Marketing Amgen, immatics, immunotherapy

Amgen has announced it is to join forces with cancer immunotherapy biotech Immatics Biotechnologies in a partnership potentially worth over …

News
handshake-1910702_960_720

Merrimack sells off drug for $1 billion and cuts workforce by 80%

January 9, 2017
Sales and Marketing Onivyde, ipsen, merrimack

Ipsen has announced the agreement to acquire oncology assets from Merrimack Pharmaceuticals, most notably the pancreatic cancer drug Onivyde, in …

News
roche

Roche’s Tecentriq scores another bladder cancer Priority Review

January 9, 2017
Sales and Marketing Roche, bladder cancer, tecentriq

Roche has announced that its immunotherapy drug Tecenetriq (atezolizumab) has been awarded Priority Review by the FDA for the treatment …

News
erik_digman_wiklund

Targovax promotes new CFO

January 6, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targovax

Erik Digman Wiklund has been named as the new chief financial officer (CFO) of Norwegian biotech Targovax, replacing Oystein Soug …

Appointment

Pfizer announce positive results for Humira biosimilar

January 6, 2017
Medical Communications, Research and Development, Sales and Marketing Humira, Pfizer, biosimilar

Pfizer has released the successful Phase 3 results to its biosimilar to AbbVie’s blockbuster Humira, meeting its primary endpoint in …

News
top_ten_1

Top Ten most popular articles on Pharmafile.com this week

January 6, 2017
Medical Communications biggest news, biggest stories, top 10, top 10 stories, top stories, top ten

The start of 2017 has already had some big stories hit the news, with many companies taking the opportunity to …

News
novartis_window

Novartis and Ionis enter $1bn cardiovascular drug deal

January 6, 2017
Medical Communications, Research and Development, Sales and Marketing Akcea, Akcea Therapeutics, Ionis, Ionis Pharmaceuticals, cardiovascular

Ionis Pharmaceuticals and one of its wholly-owned subsidiaries Akcea Therapeutics have entered into a partnership with Novartis worth potentially more …

News
peter_schurrenberger

Insider interview: Roche discusses the importance of sustainability in pharma manufacturing

January 6, 2017
Manufacturing and Production, Medical Communications Roche

Peter Schurrenberger, Chief Safety, Health and Environment Officer at Roche, discusses their recent recognition as a leader for corporate action …

News
cancer_cells

New research reveals how cancer cells grow and spread through body

January 6, 2017
Medical Communications Cancer, Cancer Research UK, ICR, Institute of Cancer Research, cancer research, cell movement

Research conducted by The Institute of Cancer Research (ICR), co-funded by Cancer Research UK, has discovered how cancer cells are …

News
astrazeneca_sign_sky

AstraZeneca acquires biotech’s unique antithrombotic drug

January 5, 2017
Medical Communications, Sales and Marketing APT, AstraZeneca, acquisition

AstraZeneca has announced that it has entered into a research collaboration, option and asset purchase agreement with APT Therapeutics, a …

News
wockhardt_hospital_mumbai

Wockhardt’s Gujarat plant hit with FDA warning letter

January 5, 2017
Manufacturing and Production FDA, Wockhardt

Indian pharma and biotech firm Wockhardt has been accused of violating current good manufacturing practice (CGMP) regulations in a letter …

News
pregnancy

Morning sickness pill scientific backing called into question

January 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Diclectin, Diclegis, Duchesnay, FDA, kim kardashian, morning sickness

Many women suffer from morning sickness during the early stages of pregnancy and some suffer from hyperemesis gravidarum, acute morning …

News
dengue_mosquito_web

Philippine FDA orders Sanofi to pull dengue vaccine ads

January 5, 2017
Medical Communications, Sales and Marketing Philippines, Sanofi, Vaccine, dengue, virus

Sanofi has suffered a major blow to its dengue immunisation programme in the Philippines after it was requested the company …

News
sheep

FDA steps up fight against superbugs with livestock ruling

January 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Antibiotics, FDA, Guidelines, Livestock, agriculture, antibiotic resistance, farmers

The FDA began the year by announcing the implementation of ‘Guidance for Industry #213’. The new rule is a voluntary …

News
alessandro-riva

Gilead makes move in oncology by snaffling Riva from Novartis

January 4, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, Novartis, oncology

Gilead Sciences have made an ambitious move to boost its oncology business by appointing current head of global oncology development …

Appointment
inotek_logo

Inotek’s glaucoma lead candidate falls at Phase 3 trial

January 4, 2017
Research and Development Glaucoma, inotek, inotek pharma

Inotek Pharmaceutical announced that its lead candidate, trabodenoson, a drug designed to treat glaucoma, had failed to outperform placebos in …

News
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026